IQVIA Holdings Inc. IQVIA Holdings Inc.

IQVIA Holdings Inc.

IQV

Rang in Aktien #560
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Aktienkurs
$266.90
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$43.93B
Veränderung (1 Tag)
-1.32%
Veränderung (1 Jahr)
30.48%
Land
US
Handel IQVIA Holdings Inc. (IQV)

Kategorie

Healthcare
Operative Marge für IQVIA Holdings Inc. (IQV)
Operative Marge zum October 2026 TTM: 13.57%
Laut den neuesten Finanzberichten und dem Aktienkurs von IQVIA Holdings Inc. beträgt die aktuelle operative Marge (TTM) 13.57%. Am Ende des Jahres 2024 lag die operative Marge bei 14.29%.
Historie der operativen Marge von IQVIA Holdings Inc. von 2010 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 13.57% -3.21%
2025 14.02% -1.89%
2024 14.29% 8.34%
2023 13.19% 5.69%
2022 12.48% 24.30%
2021 10.04% 55.90%
2020 6.44% -8.13%
2019 7.01% -1.54%
2018 7.12% -3.91%
2017 7.41% -21.34%
2016 9.42% -16.42%
2015 11.27% 4.26%
2014 10.81% 19.18%
2013 9.07% 11.29%
2012 8.15% 2.13%
2011 7.98% -20.75%
2010 10.07% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
17.97% -98.68%
US
20.42% -98.50%
US
-10.70% -100.79%
US
0.00% -
CN
22.23% -98.36%
US
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.